Monogenic Disease Variants in the Swiss Kidney Stone Cohort and Stone-Free Controls
Johannes Muench(University of Zurich), Ruxandra Bachmann‐Gagescu(Life Science Zurich), Beat Roth(University Hospital of Bern), Joana F. Silva(University of Zurich), Elena M. Cabello(University of Zurich), Olivier Bonny, Alexander Ritter(University of St.Gallen), Isabel Rubio‐Aliaga(University of Zurich), Florian Buchkremer(Kantonsspital Aarau), Grégoire Wuerzner(University of Lausanne), Daniel G. Fuster(University of Bern), Carsten A. Wagner(University of Zurich)
Cited by 0
Related Papers
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
|New England Journal of Medicine|2021|509
Tissue-Specific Amino Acid Transporter Partners ACE2 and Collectrin Differentially Interact With Hartnup Mutations
|Gastroenterology|2008|296
SLC9/NHE gene family, a plasma membrane and organellar family of Na+/H+ exchangers
|Molecular Aspects of Medicine|2013|280
Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)*
|Nephrology Dialysis Transplantation|2017|225
Traditional and emerging roles for the SLC9 Na+/H+ exchangers
|Pflügers Archiv - European Journal of Physiology|2013|187